Puri Raj K.: insider trades.
Puri Raj K. reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Puri Raj K.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Iovance Biotherapeutics, Inc. (IOVA) | Officer · Chief Regulatory Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | Iovance Biotherapeutics, Inc. | F | 4,478 | $8.7 | 256,364 | Form 4 |
| 2026-09-08 | Iovance Biotherapeutics, Inc. | M | 9,766 | $0 | 260,842 | Form 4 |
| 2026-09-01 | Iovance Biotherapeutics, Inc. | M | 5,470 | $0 | 253,584 | Form 4 |
| 2026-09-01 | Iovance Biotherapeutics, Inc. | F | 2,508 | $8.28 | 251,076 | Form 4 |
Questions
What stock did Puri Raj K. buy or sell?
Puri Raj K. reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Puri Raj K. the same person as other filers with this name?
This page covers SEC CIK 2046483 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/puri-raj-k-2046483.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.